Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Articles

Page 1 of 5

  1. Non-diabetic hypoglycemia presents a substantial diagnostic challenge due to its diverse and often nonspecific symptomatology. The resultant delay in diagnosis can lead to a myriad of misdiagnoses. This miside...

    Authors: Amin Roshdy Soliman, Rabab Mahmoud Ahmed, Amr Abdel Hady El Meligi, Ahmed Haroun Abdelmoaty, Mona A. Hegazy, Ahmed Saad, Sahar Alwakil, Nadine Alaa Sherif, Shereen Abdelghaffar, Ebtesam Fahmy, Saeed Soliman, Dina Farouk and Inass Shaltout
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:22
  2. Sex differences in cardiac function under diabetic conditions have been extensively studied. However, the impacts of type 2 diabetes on cardiac energetics between sexes remain poorly defined. Likewise, whether...

    Authors: Maryam Rahmani, Toan Pham, Linley Nisbet, David J. Crossman, Kenneth Tran, Andrew J. Taberner and June-Chiew Han
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:20
  3. Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in individuals with type 2 diabetes mellitus (T2DM), with hypertension, a common comorbidity, being a major contributor to adverse car...

    Authors: Bruno Basil, Jamila Aminu Mohammed and Izuchukwu Nnachi Mba
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:23
  4. Diabetes mellitus (DM) ignites a global epidemic, with cardiovascular complications claiming most lives among affected patients. Diabetic cardiomyopathy (DCM), a distinct cardiac dysfunction triggered by DM in...

    Authors: Xue Guan, Can Zhou, Xinyi Zhuo, Wenhui Yang and Haizhen Wang
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:18
  5. Both alkaline phosphatase (ALP) and serum creatinine (sCr) have been individually associated with adverse outcomes in patients with diabetes. This study investigates a novel composite indicator-ln[ALP × sCr]-t...

    Authors: Jianjun Wu, Dawei Yang, Youqi Zhang, Liu Ji, Xiao Tong, Guanghua Chen and Fan Yang
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:17
  6. Hypertension remains a major contributor to cardiovascular and renal complications in patients with diabetes mellitus, increasing the risk of macrovascular and microvascular disease. The 2025 AHA/ACC hypertens...

    Authors: Gaetano Santulli
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:21
  7. Authors: Sujoy Ghosh, Bipin Sethi, Sanjay Kalra, Manash P. Baruah, Abhishek Mane, Sanjay Choudhari, Anup Petare, Mayur Jadhav, Saiprasad Patil and Hanmant Barkate
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:19

    The original article was published in Cardiovascular Diabetology – Endocrinology Reports 2025 11:6

  8. Diabetes mellitus (DM) is one of the oldest diseases known to man. Type 2 diabetes is characterized by relative insulin deficiency due to pancreatic beta cell dysfunction and insulin resistance in target organ...

    Authors: Shahrazad Khorasani, Tahereh Dara, Hamidreza Dehghan, Mohsen Zabihi, Maryam Saghafi and Fatemeh Saghafi
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:16
  9. Cardiovascular disease and type 2 diabetes mellitus share inflammatory pathways; however, their combined effect on systemic inflammation remains unclear. Although chronic low-grade inflammation is recognized i...

    Authors: Jaqueline Bianchi, Fernanda Oliveira Duarte, Luciana Camillo, Krissia Franco de Godoy, Joice Margareth de Almeida Rodolpho, Bruna Dias de Lima Fragelli, Maria Clara Cavalcante Espósito, Leticia Americano Branco, Carlos Speglich, Meliza Goi Roscani, Henrique Pott and Fernanda de Freitas Anibal
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:15
  10. The cases of obesity worldwide have increased significantly, with this condition being considered a global pandemic. This pathology poses a major health problem due to its high morbidity burden. Its cause in t...

    Authors: Miguel Augusto O’Meara Novoa, Maria Camila Reyes Cajicá, Daniel Larrarte-Arenas and Jennifer Alexandra Palencia Ávila
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:13
  11. Type 2 diabetes mellitus (T2DM) impacts the development of cardiovascular disease. Prediabetes, called intermediate hyperglycemia, is diagnosed with glucose levels that do not meet the criteria for T2DM, but a...

    Authors: Wilfredo Antonio Rivera-Martínez, Aura María Salazar-Solarte, Diana Marcela Sánchez-Machado, Lunévar Figueroa Torregrosa, Robinson Pacheco, Yesit Bolaños-Moreno and María Eugenia Casanova-Valderrama
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:12
  12. Metabolic syndrome is a pressing public health issue and risk factor for the development of type 2 diabetes (T2D) and cardiovascular disease (CVD), yet clinical practice is lacking in biomarkers that represent...

    Authors: K. A. Lewis, Benjamin M. Stroebel, Alka M. Kanaya, Bradley Aouizerat, Kayla D. Longoria and Elena Flowers
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:11
  13. Type 2 diabetes mellitus is a chronic condition driven by insulin resistance and impaired beta-cell function. As beta cells gradually lose function, blood glucose levels rise, leading to clinical diabetes. Thi...

    Authors: Tahereh Dara, Mohsen Zabihi, Farahnaz Hoseinzade, Mahyar Rohani and Fatemeh Saghafi
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:10
  14. Dipeptidyl peptidase-4 inhibitors (DPP-4is) have been hypothesized to impact COVID-19 outcomes by modulating immune and inflammatory responses. This study aimed to assess the association between DPP-4i use and...

    Authors: El Walid El Hassan, Ahmad Alamer, Sarah Saad Alnami, Ibrahem Abdullah Alhawaj, Ali Hussain Alsmail, Mohammed Abdulhadi Alshawaf, Muhammad Abdulhaddi Aljazeeri, Maram Jafar Alghafli, Fatimah Yahya Alhejji, Osamah M. Alfayez, Mayar Mohammed Alharthi, Hamzah Redha Alturfi, Maha Fahad AlEssa, Rahaf Hamoud Alzuman, Sawsan M. Kurdi, Omar A. Almohammed…
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:9
  15. The objective of this report is to describe the successful use of diazoxide as a bridging therapy for a patient with opioid-induced hypoglycemia who was unable to immediately discontinue methadone treatment.

    Authors: Katherine I. Wolf, Sophia Hemmrich Sinha, Shafaq Khairi and Eric D. Buras
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:7
  16. Prolactinomas are the most common type of pituitary adenomas, typically managed with dopamine agonists. However, some cases are refractory to standard therapies, posing significant clinical challenges. This ca...

    Authors: Firdhous Alimathunisa Abdul Kather, Ariel Barkan and Shafaq Khairi
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:8
  17. Obesity is a chronic metabolic disease of global concern, often associated with Type 2 Diabetes Mellitus (T2DM). Global guidelines recommend holistic approach for T2DM management by addressing the associated c...

    Authors: Sujoy Ghosh, Bipin Sethi, Sanjay Kalra, Manash P. Baruah, Abhishek Mane, Sanjay Choudhari, Anup Petare, Mayur Jadhav, Saiprasad Patil and Hanmant Barkate
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:6

    The Correction to this article has been published in Cardiovascular Diabetology – Endocrinology Reports 2025 11:19

  18. The COVID-19 pandemic has impacted the lives of many including individuals living with chronic illnesses such as Type 2 Diabetes Mellitus (T2DM) in Ghana. This study aimed to explore how people living with T2D...

    Authors: Margaret Amankwah-Poku, Genevieva Gordon-Mensah and Kwaku Oppong Asante
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:5
  19. More information is required where the relation of diabetic neuropathy and body composition through bioimpedance is addressed. Therefore the aim of this study was to investigate the association between periphe...

    Authors: María Fernanda Garcés Pérez, Juan Enrique Santos Macías, Arnulfo González Cantú, Arnulfo Garza-Silva, Miguel Ángel Sanz Sánchez and María Elena Romero-Ibarguengoitia
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:4
  20. Type 2 diabetes is among the most prevalent endocrine disruptors. One of the most significant symptoms reported by diabetic patients is dry mouth, which results in reduced saliva buffering capacity and an incr...

    Authors: Forough Ahrari, Hamidreza Zivarifar, Tahereh Ahrari Roodi and Leili Alizadeh
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:2
  21. Gestational diabetes mellitus (GDM) cases are rising globally. This research examined the effects of GDM and diabetes mellitus whose hallmark is hyperglycemia on hormones, lipid profiles, electrolytes and anti...

    Authors: Moses Orimoloye Akinjiyan, Adeniran Samuel Atiba and Modupe Fisayo Asaolu
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:1
  22. Thyroid dysfunction in pregnancy can adversely impact maternal and fetal outcomes. However, the association between thyroid status and specific adverse outcomes needs clarity, especially in understudied regions.

    Authors: Roshni Vamja, Yogesh M, Monika Patel, Vijay Vala, Arya Ramachandran, Bhumika Surati and Jay Nagda
    Citation: Clinical Diabetes and Endocrinology 2024 10:50
  23. The ICMR INDIAB-17 study revealed a diabetes prevalence of 11.4% in India, emphasizing the need for effective treatment for glycemic control. A Phase IV study was conducted to evaluate the safety and efficacy ...

    Authors: Prabhat K Agarwal, Divendu Bhushan, Amit Bhate, Sunil Naik, Shailesh Adwani, J S Kushwaha, Sumit Bhushan, Abhishek Mane, Rujuta Gadkari, Sanjay Choudhari, Saiprasad Patil and Hanmant Barkate
    Citation: Clinical Diabetes and Endocrinology 2024 10:49
  24. This meta-analysis study aims to evaluate the Diabetes Self-Management Education and Support (DSMES) online application for reducing glycated hemoglobin levels among patients with type 1 diabetes mellitus (T1D...

    Authors: Sahebeh Usefi, Fereshteh Davoodi, Atefeh Alizadeh and Mehrshad Mohebi Far
    Citation: Clinical Diabetes and Endocrinology 2024 10:48
  25. This study aimed to determine the prevalence of Normal Weight Obesity (NWO) and evaluate its association with cardiometabolic risk factors among patients with Type 2 Diabetes Mellitus (T2DM) in Gujarat, India.

    Authors: M. Yogesh, Mansi Mody, Naresh Makwana and Jenish Patel
    Citation: Clinical Diabetes and Endocrinology 2024 10:47
  26. Metabolic-associated fatty liver disease (MAFLD) is a major public health problem worldwide. This study aimed to determine the prevalence of MAFLD and evaluate the diagnostic accuracy of the Fatty Liver Index ...

    Authors: Roshni Vamja, Yogesh M, Vijay Vala, Arya Ramachandran and Jay Nagda
    Citation: Clinical Diabetes and Endocrinology 2024 10:46
  27. The literature has been evolving to standardize gestational diabetes mellitus (GDM) diagnosis and terminology. The significance of timing in diagnosing hyperglycemia during pregnancy is underlined by evidence ...

    Authors: Fabiana Vieira Duarte de Souza Reis, Carlos Izaias Sartorão Filho, Luis Sobrevia, Caroline Baldini Prudencio, Bruna Bologna, Luana Favaro Iamundo, Adriely Magyori, Luiz Takano, Raissa Escandiussi Avramidis, Rafael Guilen de Oliveira, Marilza Vieira Cunha Rudge and Angélica Mércia Pascon Barbosa
    Citation: Clinical Diabetes and Endocrinology 2024 10:45
  28. Diabetes distress “refers to the negative emotional or affective experiences resulting from the challenge of living with the demands of diabetes.” Despite recommendations to screen for distress at regular interva...

    Authors: Anam Anil Alwani, Ravneet Kaur, Mohan Bairwa, Puneet Misra and Baridalyne Nongkynrih
    Citation: Clinical Diabetes and Endocrinology 2024 10:40
  29. Type 2 diabetes mellitus (T2DM) is a major global non-communicable disease, leading to increased morbidity and mortality. Its prevalence in Nigeria is driven by various risk factors. This review assesses the n...

    Authors: Michael Adeyemi Olamoyegun, Kehinde Alare, Samson Adedeji Afolabi, Nicholas Aderinto and Taiwo Adeyemi
    Citation: Clinical Diabetes and Endocrinology 2024 10:43
  30. Effective diabetic retinopathy screening (DRS) programmes are important in preventing vision impairment and blindness caused by diabetes. This study focuses on identifying the factors affecting attendance or n...

    Authors: Katie Curran, Munir Ahmed, Mirza Manbira Sultana, Salissou Moutari, Mohammad Awlad Hossain, Laura Cushley, Tunde Peto, Lutful Husain, Bedowra Zabeen and Nathan Congdon
    Citation: Clinical Diabetes and Endocrinology 2024 10:41
  31. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing health concern and the risk of its development is connected with the increasing prevalence of metabolic syndrome (MetS) which occur...

    Authors: Bruno Basil, Blessing K. Myke-Mbata, Onyinye E. Eze and Augustine U. Akubue
    Citation: Clinical Diabetes and Endocrinology 2024 10:39
  32. Monacolin-K, the active component of red yeast rice (RYR), reduces cholesterol by inhibiting HMG-CoA reductase. Following safety concerns, the European Food Safety Authority (EFSA) recommended limiting Monacol...

    Authors: Alessia Izzo, Rosa Costanzo, Lucia De Martino and Salvatore Di Napoli
    Citation: Clinical Diabetes and Endocrinology 2024 10:38
  33. Propylthiouracil is an antithyroid medication that is associated with ANCA positivity, often in the absence of clinically overt vasculitis. Propylthiouracil-induced ANCA-associated vasculitis (AAV) is characte...

    Authors: Ro’a Khalaf, Deema Mhesin, Hasan Abu Salim, Sari Taha and Waddah Abed
    Citation: Clinical Diabetes and Endocrinology 2024 10:42
  34. Type 2 diabetes mellitus (T2DM) is a multifaceted metabolic disorder. Over the past decade, the potential role of Growth Hormone (GH) and Insulin-like Growth Factor-1 (IGF-1) in the pathogenesis and progressio...

    Authors: Hasanain MohammedHuthaifa AbdlWhab, Araz Al-Saffar, Osama Abbas Mahdi and Rafid Badri Alameri
    Citation: Clinical Diabetes and Endocrinology 2024 10:36
  35. We present one of only seven reported cases of a catecholamine-secreting adrenal neuroblastoma in an adult. The case is used as a platform to discuss key biochemical, genomic and imaging considerations that ar...

    Authors: Joanna Y. Gong, Debbie Gordon, Sylvia Ye, Bill Fleming, Jason Tan, Toby Hulf, Maryam Shamassi, Lisa M. Orme, Nezor Houli, Emma Boehm, Christopher J. Yates and Dev A. Kevat
    Citation: Clinical Diabetes and Endocrinology 2024 10:37
  36. Diabetes mellitus (DM) is one of the most prevalent chronic diseases worldwide. Despite the existence of national strategies to prevent potential complications, DM-related morbidities and mortality continue to...

    Authors: Sentayehu Admasu Saliya, Taye Mezgebu Ashine, Asnakech Zekiwos Heliso, Getachew Ossabo Babore, Bethelhem Birhanu, Awoke Girma Hailu, Sisay Foga Sebro, Elias Ezo and Selamawit Wondale Begizew
    Citation: Clinical Diabetes and Endocrinology 2024 10:34
  37. Sarcopenia is defined by low measures of muscle quantity, quality and reduced physical performance. It is associated with higher levels of frailty. Individuals with diabetes mellitus (DM) undergo sarcopenia at...

    Authors: Manal Ahmad, Abdulla Mohamed, Dimitri Amiras, Francesca Siracusa, Joseph Shalhoub and Alun Huw Davies
    Citation: Clinical Diabetes and Endocrinology 2024 10:31
  38. Constipation, which affects 16% of adults worldwide, is a chronic health problem characterized by unsatisfactory frequency of bowel movements, causing pain, bloating or incomplete bowel movements. The study ai...

    Authors: Wubshet Nebiyu Mogess, Tefera Belsty Mihretie, Mezgebu Legesse Habte, Teka Obsa Feyisa, Bilisuma Girma Areda, Ebsa Tofik Ahmed, Getahun Chala Diribsa, Mastewal Zeleke, Natan Muluberhan Alemseged, Eyobel Amentie, Tegenu Balcha Wodajo and Tewekel Reshid Borushe
    Citation: Clinical Diabetes and Endocrinology 2024 10:33
  39. There are scant data relating to prognostic biomarkers for chronic kidney disease (CKD) complicating type 1 diabetes. The aim of this study was to assess the performance of the plasma protein biomarker-based P...

    Authors: Timothy M. E. Davis, Wendy A. Davis, Scott D. Bringans, James K. C. Lui, Tasha S. C. Lumbantobing, Kirsten E. Peters and Richard J. Lipscombe
    Citation: Clinical Diabetes and Endocrinology 2024 10:30
  40. Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, characterised by its multifactorial nature and intricate interplay of genetic, hormonal, and environmenta...

    Authors: Emmanuel Kokori, Gbolahan Olatunji, Rosemary Komolafe, Ikponmwosa Jude Ogieuhi, Bonaventure Ukoaka, Irene Ajayi and Nicholas Aderinto
    Citation: Clinical Diabetes and Endocrinology 2024 10:27
  41. Obesity is rising globally. Normal weight obesity (NWO) and normal weight central obesity (NWCO) despite normal BMI pose added metabolic risks. Limited data on these phenotypes among Indian doctors merits inve...

    Authors: Yogesh M, Nidhi Trivedi, Naresh Makwana, Pagadala Hari Priya PVM Krishna and Kadalarasu D
    Citation: Clinical Diabetes and Endocrinology 2024 10:28
  42. Ceramides have recently been identified as novel biomarkers associated with diabetes mellitus (DM) and major adverse cardiac and cerebrovascular events (MACCE). This study aims to explore their utility in diag...

    Authors: Debora Leonor Junqueira, Alexandre Biasi Cavalcanti, Juliana Maria Ferraz Sallum, Erika Yasaki, Isabella de Andrade Jesuíno, Alline Stach, Karina Negrelli, Leila de Oliveira Silva, Marcela Almeida Lopes, Adriano Caixeta, Mark YY Chan, Jianhong Ching, Valdemir Malechco Carvalho, Andrea Tedesco Faccio, Jeane Tsutsui, Edgar Rizzatti…
    Citation: Clinical Diabetes and Endocrinology 2024 10:32
  43. Type 1 diabetes mellitus (T1D) is an autoimmune disease caused by destruction of pancreatic islet beta-cells. There is significant residual beta-cell function, measured through circulating C-peptide, present a...

    Authors: Adya Rao, Lauren M Quinn and Parth Narendran
    Citation: Clinical Diabetes and Endocrinology 2024 10:26

    The Correction to this article has been published in Cardiovascular Diabetology – Endocrinology Reports 2025 11:3

  44. Elevated blood glucose concentration, also known as hyperglycemia, has been identified as a significant factor influencing the prognosis of COVID-19, alongside the impact of the SARS-CoV-2 infection itself.

    Authors: Faranak Salajegheh, Somayyeh Salajegheh, Mohsen Nakhaie, Niloofar Farsiu, Seyedeh Mahdieh Khoshnazar, Reza Sinaei, Mehrdad Farrokhnia and Soheila Torabiyan
    Citation: Clinical Diabetes and Endocrinology 2024 10:29

Annual Journal Metrics

  • Speed
    Submission to first editorial decision (median days): 6
    Submission to acceptance (median days): 75

    Usage 2024
    Downloads: 278,486
    Altmetric mentions: 184